Innovations in infectious disease testing: Leveraging COVID-19 pandemic technologies for the future

Research output: Contribution to journalArticlepeer-review

Abstract

Innovations in infectious disease testing have improved our abilities to detect and understand the microbial world. The 2019 novel coronavirus infectious disease (COVID-19) pandemic introduced new innovations including non-prescription “over the counter” infectious disease tests, mass spectrometry-based detection of COVID-19 host response, and the implementation of artificial intelligence (AI) and machine learning (ML) to identify individuals infected by the severe acute respiratory syndrome - coronavirus – 2 (SARS-CoV-2). As the world recovers from the COVID-19 pandemic; these innovative solutions will give rise to a new era of infectious disease tests extending beyond the detection of SARS-CoV-2. To this end, the purpose of this review is to summarize current trends in infectious disease testing and discuss innovative applications specifically in the areas of POC testing, MS, molecular diagnostics, sample types, and AI/ML.

Original languageEnglish (US)
JournalClinical Biochemistry
DOIs
StateAccepted/In press - 2022

Keywords

  • Artificial intelligence
  • Direct to consumer
  • Machine learning
  • Mass spectrometry
  • Molecular diagnostics
  • Over the counter
  • Point-of-care testing

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Innovations in infectious disease testing: Leveraging COVID-19 pandemic technologies for the future'. Together they form a unique fingerprint.

Cite this